Daniel Leynadier

Statistics

Publications

Citations

294

H-Index

Active since

1989

Affiliations

Centro de Investigaciones Biológicas Margarita Salas(Current)

Bioénergétique et Ingénierie des Protéines

Consejo Superior de Investigaciones Científicas

Daniel Leynadier is an author at Centro de Investigaciones Biológicas Margarita Salas specializing in microtubule-associated proteins, enzyme inhibition, and binding affinity to tubulin.

Publications per year

1989–1998

Publications

Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.

Concepción de Inés, Daniel Leynadier, Vincent Peyrot et al. · PubMed · 1994 · 71 citations

Medicine, Oncology, Pharmacology +17

Tubulin Secondary Structure Analysis, Limited Proteolysis Sites, and Homology to FtsZ

José M. de Pereda, Daniel Leynadier, Juan A. Evangelio et al. · Biochemistry · 1996 · 60 citations

Life Sciences, Biochemistry, Molecular Biology +17

Mechanism of binding of the new antimitotic drug MDL 27048 to the colchicine site of tubulin: Equilibrium studies

Vincent Peyrot, Daniel Leynadier, M. Sarrazin et al. · Biochemistry · 1992 · 57 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048

Vincent Peyrot, Daniel Leynadier, M. Sarrazin et al. · Journal of Biological Chemistry · 1989 · 50 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

The Active GTP- and Ground GDP-Liganded States of Tubulin Are Distinguished by the Binding of Chiral Isomers of Ethyl 5-Amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-<i>b</i>]pyrazin-7-yl Carbamate

Pascale Barbier, Vincent Peyrot, Daniel Leynadier et al. · Biochemistry · 1998 · 22 citations

Life Sciences, Biochemistry, Molecular Biology +10

1–5 of 7